BioCentury
ARTICLE | Clinical News

Alseres preclinical data

September 1, 2008 7:00 AM UTC

ALSE-100 formed bone nodules by stimulating cell differentiation and mineralization, and inhibited bone resorption, osteoclast development, and osteoclast activity in vitro. ALSE-100 is a Rho-A inhibi...